CEL-SCI Corp (CVM)

US · Healthcare · Biotechnology

$1.36+8.80%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

Net profit

$-5.5M

Profit YoY

+16.8%

EPS

$-0.68

EPS estimate

$0.00

Market cap

$20.3M

Forward P/E

23.0

P/B

2.95

Book value

$0.81

EPS (TTM)

$-2.15

52-week high

$13.48

52-week low

$0.89

50-day MA

$1.24

200-day MA

$4.13

Beta

0.65

Analysts rate CEL-SCI Corp a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $15.00.

Insiders

6.31%

Institutions

4.69%

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for CEL-SCI Corp — free to start.

Data updated 2026-08-05.